Searched for
ALKEM LABS STOCK
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...- Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsMarkets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. Wh...
- Add Alkem Laboratories, target price Rs 5,700: HDFC SecuritiesHDFC Securities suggests adding Alkem Laboratories shares, targeting Rs 5,700. Alkem, a large pharmaceutical company, reported its financia...
- Add Alkem Laboratories, target price Rs 6,180: HDFC SecuritiesHDFC Securities recommends buying shares of Alkem Laboratories. They set a target price of Rs 6,180. The current market price is Rs 5,535. ...
- Add Alkem Laboratories, target price Rs 5520: HDFC SecuritiesAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 60260.76 Crore) operating in Phar...
- Alkem Labs plunges more than 13%, sees biggest single-day fall in over 3 years on tax evasion allegationIn September last year, the tax department conducted surveys on the offices and premises of the company after receiving intelligence regard...
- Chart Check: Rectangle pattern breakout could take this pharma stock to fresh 52-week highs in next 3-6 monthsAlkem stock price largely moved in a range from May 2022 where Rs 3,300-3,400 acted as a stiff resistance while on the downside Rs 2,800 ac...
- Buy Alkem Laboratories, target price Rs 3500: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 35273.47 Crore) operating in Phar...
- Buy Alkem Lab, target price Rs 3,300: Angel BrokingThe pharma company is expected to outperform the Indian Pharmaceutical market (IPM) by 1.5 times growth rate for the next 2 years.
- Stock pick of the week: Why analysts are betting on Alkem LabsA rise in margins in the coming years, improved domestic business, leadership position in some segments, and the correction in its stock pr...
- Buy Alkem Laboratories, target Rs 2,307: Anand RathiBuy Alkem Laboratories at a price target of Rs 2307.
- Stock pick of the week: What makes Alkem Lab a good long term buyAlkem Lab is reasonably priced compared to its competitors and the recent correction has offered a good opportunity to long-term investors.
- Alkem stock up 5% as its Gujarat unit gets USFDA nodShares of Alkem Labs today went up by over 5 per cent after the company said one of its manufacturing plants in Gujarat has obtained establ...
- Alkem Labs, Dr Lal PathLabs listings to help drive expansionAlkem Labs and Dr Lal PathLabs made an impressive start at the bourses on Wednesday, opening 31 per cent and 50 per cent higher from their ...
- 2015: Best year for IPOs since 2010; Dr Lal surges 50%, Alkem gains 31% on street debutOn Dr Lal PathLabs, Bansal said valuation of the company appears expensive after the strong listing and investors should wait for the compa...
- Alkem, Dr Lal PathLabs to make stock market debut on December 23Dr Lal's IPO too was a huge success with 33.41 times oversubscription. The price band was fixed at Rs 540-550 per share for the Rs 638 cror...
Load More
